Furthermore, mutations in the PIK3CA gene were associated with a lower risk of tumour recurrence (Hazard Ratio HR = 0.26; 95% CI: 0.11–0.62; p = 0.018). The gene discussed is PIK3CA; the disease is neoplasm.